Reviewing and approving prior authorizations has been a necessary but often cumbersome challenge.
Author: Daniel Gest
By 2025, it’s been estimated that healthcare data will represent 36% of the world’s data volume.
The No Surprises Act (NSA) had several top stories from 2022 including the recent Department of Health and Human Services (HHS) announcement that enforcement of a key requirement under the act would not start January 1, 2023, as previously scheduled.
At the first Becker’s Payer Issues Roundtable event on November 7-8, a leadership panel discussed payers’ top priorities.
The Consolidated Appropriations Act (CAA) of 2021 is long overdue legislation aiming to improve prescription drug price transparency and shed light on the role of pharmacy benefit managers (PBMs).
Advertisement
Individualized treatment plans for chronic diseases that take into account personal ethnic, socioeconomic and age-related factors can deliver better outcomes. But scaling individualized care across complex populations is a challenge.
Utilization management (UM) has become a huge administrative burden for both providers and payers due to multiple data sources and manual processes. By using artificial intelligence (AI) technology and real-time data, all parties can significantly reduce current utilization management review…
Many payer-provider enablement solutions look great on a whiteboard.
When facing economic uncertainty, some people may avoid certain habits such as buying healthy foods or their gym membership because of the cost. That can lead to development or progression of chronic disease, and stress, anxiety and depression can only…